Clover Biopharmaceuticals (China)

Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial

Peter Richmond, Lara Hatchuel, Min Dong et al. · The Lancet · 2021 · 279 citations · Full text

S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates

Joshua G. Liang, Danmei Su, Tian‐Zhang Song et al. · Nature Communications · 2021 · 160 citations · Full text

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial

Lulu Bravo, Igor Smolenov, Htay Htay Han et al. · The Lancet · 2022 · 112 citations · Full text

Vaccinology, Vaccine Safety, Vaccination +9

Improvement of Pharmacokinetic Profile of TRAIL via Trimer-Tag Enhances its Antitumor Activity in vivo

Haipeng Liu, Danmei Su, Jinlong Zhang et al. · Scientific Reports · 2017 · 90 citations · Full text

Cryo-electron Microscopy Structure of S-Trimer, a Subunit Vaccine Candidate for COVID-19

Jiahao Ma, Danmei Su, Yinyan Sun et al. · Journal of Virology · 2021 · 45 citations · Full text